REDWOOD CITY, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that two of the ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Orphan Technologies, a company dedicated to helping patients control their homocysteine levels, today announced that the first patients have been treated in a Phase ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Orphan Technologies, a company dedicated to helping patients control their homocysteine levels, today announced that OT-58 for the treatment of cystathionine beta ...
AUSTIN, Texas, Dec. 1, 2020 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative ...
HCU is a rare autosomal recessive inherited sulfur amino acid metabolism disorder primarily caused by a cystathionine beta-synthase deficiency (CBS). HCU patients have a broad spectrum of age (older ...
- Rare metabolic disorder with no adequate treatment options affects an estimated 12,113 patients according to strict ICD-10 diagnostic claims data - Healthcare costs for patients with ICD-10 ...
In a new paper, researchers describe finding the gene that causes Mexican cavefish to lose their vision. The same gene responsible for this evolutionary change in the fish is also responsible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback